Background: Varicose veins (VVs) are a common chronic venous disorder with a complex pathophysiology involving immune dysregulation, inflammation, and genetic predisposition. This study aims to identify immune-related causal factors in the pathogenesis of VVs using Mendelian randomization (MR).

Methods: A two-sample MR analysis was conducted to assess the causal relationships between immune cell phenotypes and VVs. Genetic variants were used as instrumental variables, and data were derived from the Finland and GWAS catalog. Inverse variance weighting (IVW) was used as the primary method, supported by sensitivity analyses such as MR-Egger, weighted median, and weighted mode.

Results: A total of 79 immunophenotypes were identified as significantly associated with VVs, including 19 related to B-cells, 6 to conventional dendritic cells (cDCs), 6 to T-cell maturation stages, 6 to monocytes, 12 to myeloid cells, 11 to TBNK cells, and 17 to regulatory T-cells (Tregs). Of these, 8 immunophenotypes remained significant after multiple testing correction (FDR < 0.05). Specifically, high expression of CD86 on myeloid DCs, CD33 expression on myeloid cells (e.g., basophils and HLA DR+ subsets), increased SSC-A on lymphocytes, and associations with CD39+ regulatory T cells showed significant correlations with VVs.

Conclusion: This study highlights the involvement of immune cells in the pathogenesis of VVs. High expression of CD86 on myeloid DCs and SSC-A on lymphocytes may serve as potential markers for predicting VVs risk, while the protective role of CD39+ Tregs suggests a new direction for immune modulation therapy. Further research is needed to validate these findings across diverse populations and explore their clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.avsg.2025.01.030DOI Listing

Publication Analysis

Top Keywords

immune cell
8
cell phenotypes
8
varicose veins
8
mendelian randomization
8
pathogenesis vvs
8
myeloid cells
8
high expression
8
expression cd86
8
cd86 myeloid
8
myeloid dcs
8

Similar Publications

Targeting RNA splicing modulation: new perspectives for anticancer strategy?

J Exp Clin Cancer Res

January 2025

Department of Pharmacology, School of Pharmacy, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province, 110122, P. R. China.

The excision of introns from pre-mRNA is a crucial process in the expression of the majority of genes. Alternative splicing allows a single gene to generate diverse mRNA and protein products. Aberrant RNA splicing is recognized as a molecular characteristic present in almost all types of tumors.

View Article and Find Full Text PDF

Clonal hematopoiesis of indeterminate potential (CHIP) is a condition where blood or bone marrow cells carry mutations associated with hematological malignancies. Individuals with CHIP have an increased risk of developing hematological malignancies, atherosclerotic cardiovascular disease, and all-cause mortality. Bone marrow transplantation (BMT) of cells carrying CHIP mutations into irradiated mice are useful procedures to investigate the dynamics of clonal expansion and potential therapeutic strategies, but myeloablative conditioning can induce confounding effects.

View Article and Find Full Text PDF

Background: The progression of bladder cancer (BC) from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) significantly increases disease severity. Although the tumor microenvironment (TME) plays a pivotal role in this process, the heterogeneity of tumor cells and TME components remains underexplored.

Methods: We characterized the transcriptomes of single cells from 11 BC samples, including 4 NMIBC, 4 MIBC, and 3 adjacent normal tissues.

View Article and Find Full Text PDF

Osteosarcoma (OS) is a commonly observed malignant tumor in orthopedics that has a very poor prognosis. The endosomal sorting complex required for transport (ESCRT) is important for the development and progression of cancer and may be a significant target for cancer therapy. First, we built a prognostic signature using 7 ESCRT-related genes (ERGs) to predict OS patient prognosis.

View Article and Find Full Text PDF

Lewy body diseases and the gut.

Mol Neurodegener

January 2025

Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.

Gastrointestinal (GI) involvement in Lewy body diseases (LBDs) has been observed since the initial descriptions of patients by James Parkinson. Recent experimental and human observational studies raise the possibility that pathogenic alpha-synuclein (⍺-syn) might develop in the GI tract and subsequently spread to susceptible brain regions. The cellular and mechanistic origins of ⍺-syn propagation in disease are under intense investigation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!